Lakefront Biotherapeutics NV

Lakefront Biotherapeutics NV(LKFT)價格預測

$28.500

-0.376 (-1.32%)收盤時

價格預測

1-Day Price Prediction
-1.04%
1-Week Prediction
-5.59%
1-Month Prediction
2026 Prediction
2030 Prediction

在 App 中開啟以解鎖更長週期的預測。

Loading chart…

LKFT 相似圖表分析預測

Alphio's LKFT stock price prediction model matches the current Lakefront Biotherapeutics NV tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $28.20 (-1.04%). The 1-week path is $26.91 (-5.59%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

該買進 Lakefront Biotherapeutics NV 股票嗎?

Lakefront Biotherapeutics appears to be a good buy right now due to its recent positive developments and favorable financial metrics. The current price is $28.88, which is below the analyst's revised price target of $26, indicating potential upside. The company has a strong gross margin of 99.95% reported in Q4 2025, and its recent FDA Orphan Drug Designation for Gamgertamig enhances its market potential. However, the main risk is the high forward P/E ratio of 344.83, indicating that the stock may be overvalued if growth does not materialize as expected.

LKFT 股價於 Monday 收在 $28.50,此前下跌 -1.32%

Lakefront Biotherapeutics NV (LKFT) last closed at $28.5, losing -1.32%. These facts feed the 1-day and 1-week LKFT price prediction above.

預測驅動因素

Lakefront Biotherapeutics NV(LKFT)的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。

Similar patterns

Positive

Bullish

Seasonality

Positive

Bullish

SMA 20

Positive

Bullish

SMA 200

Positive

Bullish

相似圖表形態

近期走勢與 LKFT 最接近的股票,依相似度排序。

LKFT 季節性分析

Loading chart…

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始